Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza
This federal contract opportunity has been awarded to on September 30, 2025.
Award Information
This solicitation resulted in an award to for approximately $339,189,481 on September 30, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
- Award Number
- 75A50125C00017
- Award Amount
- $339,189,481
- Award Date
- September 30, 2025
Key Takeaways
- No response deadline specified - contact the agency for details
- Set-aside for No Set Aside businesses
- Work to be performed in WASHINGTON, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 75A50125C00017
- Opportunity Type
- Award Notice
- Sub-Agency
- OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Posted Date
- Tuesday, October 14, 2025
- Response Deadline
- Not specified
- PSC Code
- AN13
- Set-Aside
- No Set Aside
- Place of Performance
- WASHINGTON, DC, 20515
- Status
- Active
Description
No description available. View the full opportunity on SAM.gov for complete details.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in WASHINGTON, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
